Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -143.30% is 256% below its 5-year average of -40.25%, near the low end of its 5-year range (-143.30%–-15.50%).
100.15% below its 12-month average of -71.59%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 15.19%.
RETURN ON ASSETS (ROA)
-143.30%
RETURN ON ASSETS (ROA) AVG TTM
-71.59%
RETURN ON ASSETS (ROA) AVG 3Y
-49.53%
RETURN ON ASSETS (ROA) AVG 5Y
-40.25%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-100.15%
CURRENT VS 3Y AVG
-189.29%
CURRENT VS 5Y AVG
-256.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-30.84%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-364.58%
vs the sector median at left
Werewolf Therapeutics, Inc.
Market Cap
$45.20M
Return on Assets (ROA)
-143.30%
TTM Avg
-71.59%
3Y Avg
-49.53%
5Y Avg
-40.25%
Market Cap
$45.37M
Return on Assets (ROA)
70.17%
TTM Avg
-36.93%
3Y Avg
-46.92%
5Y Avg
-57.84%
Market Cap
$44.32M
Return on Assets (ROA)
-56.31%
TTM Avg
-47.91%
3Y Avg
-41.18%
5Y Avg
-35.79%
Market Cap
$44.31M
Return on Assets (ROA)
-87.60%
TTM Avg
-55.36%
3Y Avg
-44.79%
5Y Avg
-43.77%
Market Cap
$43.93M
Return on Assets (ROA)
-128.10%
TTM Avg
-35.87%
3Y Avg
-35.25%
5Y Avg
-29.40%
Market Cap
$43.68M
Return on Assets (ROA)
39.10%
TTM Avg
-36.27%
3Y Avg
-59.86%
5Y Avg
-86.70%
Market Cap
$42.97M
Return on Assets (ROA)
-57.95%
TTM Avg
4.78%
3Y Avg
-64.05%
5Y Avg
-66.64%
Market Cap
$47.83M
Return on Assets (ROA)
-11.23%
TTM Avg
-20.22%
3Y Avg
-14.66%
5Y Avg
-10.97%
Market Cap
$42.63M
Return on Assets (ROA)
-5.70%
TTM Avg
-13.47%
3Y Avg
-29.01%
5Y Avg
-32.57%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Werewolf Therapeutics, Inc. (HOWL) | $45.20M | -143.30% | -71.59% | -49.53% | -40.25% |
| DarioHealth Corp. (DRIO)vs › | $45.37M | 70.17% | -36.93% | -46.92% | -57.84% |
| CVRx, Inc. (CVRX)vs › | $44.32M | -56.31% | -47.91% | -41.18% | -35.79% |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $44.31M | -87.60% | -55.36% | -44.79% | -43.77% |
| Nano-X Imaging Ltd. (NNOX)vs › | $43.93M | -128.10% | -35.87% | -35.25% | -29.40% |
| SANUWAVE Health Inc. (SNWV)vs › | $43.68M | 39.10% | -36.27% | -59.86% | -86.70% |
| BioStem Technologies, Inc. (BSEM)vs › | $42.97M | -57.95% | 4.78% | -64.05% | -66.64% |
| Precision Optics Corporation, Inc. (POCI)vs › | $47.83M | -11.23% | -20.22% | -14.66% | -10.97% |
| Precipio, Inc. (PRPO)vs › | $42.63M | -5.70% | -13.47% | -29.01% | -32.57% |
| Lite Strategy, Inc. (LITS)vs › | $48.83M | -166.66% | -126.93% | -59.31% | -48.60% |
ROA
-143.3%
ROE
-212.4%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -87.64% |
| 2024-12-31 | -55.55% |
| 2023-12-31 | -21.37% |
| 2022-12-31 | -33.58% |
| 2021-12-31 | -27.88% |
| 2020-12-31 | -15.50% |
| 2019-12-31 | -50.69% |
